Definitive Contract 75N93022C00006
Award Date
1/10/22
Potential Completion Date
1/9/24
Potential Value
$598K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Qrono, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Carson, PA 15203, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
11
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Food and Drug Administration (FDA), a civilian agency, to Qrono, Inc., a for-profit company specializing in medical and scientific research and development. The $694,584.58 cost-plus-fixed-fee contract, titled "Computational Drug Delivery: Leveraging Predictive Models to Develop Bioequivalent Generic Long-Acting Injections," is focused on developing innovative drug delivery systems and immunotherapy approaches. The contract has an ultimate...
This is a federal contract award from the U.S. Army Medical Command (MEDCOM) to Qrono, Inc., a small business. The contract is a Small Business Innovation Research (SBIR) Phase I award valued at $149,927.50 with a firm fixed price. The contract was awarded on September 15, 2015 and has an ultimate completion date of July 31, 2017. The contract is focused on medical and scientific research and development, with Qrono, Inc. specializing in innovative drug delivery systems and immunotherapy...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awarded a $298,596 definitive contract to Sanaria Inc. of Potomac, MD for Research Type Small Business Innovation Research Program Phase I Action. The contract is a firm fixed price award with a period of performance from August 30, 2022 through April 1, 2024. The place of performance is Potomac, MD and the contract has a total small business set aside...
The Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $599,980 firm fixed price contract to Tendel Therapies, Inc., a small business, for research and development services related to genetic adjuvants to promote durable anti-influenza stem antibodies in older adults. This contract was awarded under the NIH and Centers for Disease Control and Prevention's Small Business Innovation Research (SBIR) program,...
This is a federal contract award from the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Adjuvance Technologies Inc. for the preclinical development of a semisynthetic saponin immunological adjuvant called Titerquil-1055 in the context of an influenza vaccine. The contract is a definitive, firm-fixed-price contract with a potential value of $1,471,319.00 and a completion date of December 15, 2020. The contract is...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $24,209 purchase order to Chronolog Corp. to deliver a whole blood/optical lumi-aggregation system as described in solicitation AMBIS 2183761. Performance will take place in Havertown, Pennsylvania over a period of approximately four months concluding in late December 2023. The firm fixed price contract was awarded to the prime contractor Chronolog Corp. to...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Aphios Corp, a minority-owned for-profit organization, for the development of "CRITICAL FLUID NANOSOMES FOR EFFECTIVE TARGETED DELIVERY AND MANUFACTURE OF SIRNA-BASED THERAPEUTICS." The firm-fixed-price contract has a potential value of $299,591.00 and a completion date of...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price definitive contract valued at $585,999.00 to Protein Innovation Labs, Inc., a small business concern, for the provision of reagents to support immunologic analysis of non-mammalian models. This contract was awarded under the National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC) Small Business Innovation...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Small Business Innovation Research (SBIR) Phase I contract to Inimmune Corp, a small business biotechnology company, for the "Discovery of New Small Molecule TLR4 Agonists for the Treatment of Allergic Rhinitis". The $631,425.00 Firm Fixed Price contract has a period of performance from July 31, 2018 to July 31, 2020. Inimmune Corp, which has...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $31,997,746.00 cost plus fixed fee contract to Leidos Biomedical Research Inc. to support clinical testing of vaccines against seasonal or pandemic influenza viruses from September 12, 2022 through August 24, 2028. Leidos Biomedical Research Inc. will serve as the prime contractor and will utilize two subcontracts with the University of Pittsburgh, which will be responsible for housing and caring...